NexGel Inc (NXGL)
3.06
-0.12
(-3.77%)
USD |
NASDAQ |
Nov 15, 16:00
3.10
+0.04
(+1.31%)
After-Hours: 20:00
NexGel Research and Development Expense (TTM): 0.097M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.097M |
| March 31, 2024 | 0.076M |
| December 31, 2023 | 0.103M |
| September 30, 2023 | 0.129M |
| June 30, 2023 | 0.316M |
| March 31, 2023 | 0.372M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.367M |
| September 30, 2022 | 0.342M |
| June 30, 2022 | 0.149M |
| March 31, 2022 | 0.048M |
| December 31, 2021 | 0.031M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.031M
Minimum
Dec 2021
0.372M
Maximum
Mar 2023
0.1845M
Average
0.129M
Median
Sep 2023
Research and Development Expense (TTM) Benchmarks
| The Cooper Companies Inc | 154.10M |
| Staar Surgical Co | 52.80M |
| OrthoPediatrics Corp | 10.34M |
| Innovative Eyewear Inc | 0.7866M |
| Perspective Therapeutics Inc | 28.53M |